Skip to main content

MARSHALL WACE, LLP

Position in ADCT — ADC Therapeutics SA

CIK 1318757 LONDON, X0

Position in ADCT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$170,546
-$469,426 QoQ
Shares Held
45,479
-71.6% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. ADCT ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADCT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $170,546 45,479
2025-09-30 $639,972 159,993
2024-03-31 $1,092,161 243,243
2023-12-31 $36,267 21,848
2023-09-30 $393,489 438,673
2023-06-30 $784,874 365,058
2023-03-31 $307,474 157,679
2020-12-31 $1,906,739 59,567
2020-09-30 $6,454,559 195,652